Those results indicate tumor markers FHIT, PCNA, Ki-67 should be used jointly in designing an intelligent medical decision system to diagnose the different diseases of Cushing's syndrome as none of the markers is highly characteristic but all are useful. This evidence concerns the gene MKI67 and Cushing syndrome due to macronodular adrenal hyperplasia.